Sensex, Nifty trade flat; Sun Pharma jumps 6%, RCom most active

Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal

Benchmark indices continued to consolidate in afternoon after hitting life-time highs.

The 30-share BSE Sensex was up 36.33 points at 34,046.94 and the 50-share NSE Nifty rose 1.30 points to 10,532.80.

About 1,422 shares advanced against 1,094 declining shares on the BSE.

Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein thrombosis.

For more information ✆ – 0731-6642300 or visit- http://www.epicresearch.co/festive-offers

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300